- Ticker
- ABOS
- Price
- 3.89
- Stock movement up
- +0.04 (1.04%)
- Company name
- Acumen Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 159.20M
- Ent value
- 8.27M
- Price/Sales
- -
- Price/Book
- 0.81
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 1.83%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-04-08
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABOS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.81 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 40.93M |
| EPS (TTM) | -0.95 |
| FCF per share (TTM) | -0.69 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -39.40M |
| Net income (TTM) | -38.34M |
| EPS (TTM) | -0.95 |
| EPS (1y forward) | -1.23 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 157.54M |
| Net receivables | 121.00K |
| Total current assets | 202.56M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 203.26M |
| Accounts payable | 2.08M |
| Short/Current long term debt | 133.00K |
| Total current liabilities | 6.61M |
| Total liabilities | 6.61M |
| Shareholder's equity | 196.65M |
| Net tangible assets | 196.65M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -27.59M |
| Capital expenditures (TTM) | 158.00K |
| Free cash flow (TTM) | -27.75M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -19.50% |
| Return on Assets | -18.86% |
| Return on Invested Capital | -19.48% |
| Cash Return on Invested Capital | -14.10% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.91 |
| Daily high | 4.00 |
| Daily low | 3.85 |
| Daily Volume | 143K |
| All-time high | 20.28 |
| 1y analyst estimate | 15.83 |
| Beta | - |
| EPS (TTM) | -0.95 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 6 May 2024 |
Downside potential
Loading...
Downside potential data
| ABOS | S&P500 | |
| Current price drop from All-time high | -80.82% | -0.85% |
| Highest price drop | -90.83% | -56.47% |
| Date of highest drop | 9 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -67.65% | -11.35% |
| Avg time to new high | 696 days | 13 days |
| Max time to new high | 695 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
159.20M
Marketcap category
Small-cap
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Employees
14
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page